Notizie AIOM – anno XV n. 614

30 Gennaio 2017

Radiation Therapy for Glioblastoma: What Is New and What Is Missing in the ASCO-Endorsed ASTRO Guidelines

January 25th, 2017 - An ASCO Special Article in the Journal of Clinical Oncology by Sulman et al,1 reviewed in this issue of The ASCO Post, issued ASCO’s endorsement of the American Society for Radiation Oncology (ASTRO) guidelines on radiation therapy for adult patients ...
Leggi tutto

30 Gennaio 2017

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care based on similar survival to and less toxicity than adjuvant 5-fluorouracil/folinic acid in patients with resected pancreatic cancer. Other clinical trials have shown better survival and tumour response ...
Leggi tutto

30 Gennaio 2017

SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers

January 26th, 2017 - People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy trial devoted to rare cancers. Despite their ...
Leggi tutto

30 Gennaio 2017

FDA confirms elevated levels of belladonna in certain homeopathic teething products

January 27th, 2017 - The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label. The agency ...
Leggi tutto

30 Gennaio 2017

27 gennaio 2017 – Aggiornamento: Linea guida relativa alle avvertenze degli eccipienti da inserire negli stampati dei medicinali omeopatici

30 Gennaio 2017

CHMP Recommends Approval of Maintenance Lenalidomide in Post-ASCT Myeloma

January 28th, 2017 - The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of lenalidomide as a maintenance therapy following autologous stem cell transplant (ASCT) for patients with newly diagnosed multiple myeloma, according to ...
Leggi tutto

27 Gennaio 2017

American Society of Clinical Oncology Policy Brief: FDA’s Regulation of Electronic Nicotine Delivery Systems and Tobacco Products

Since the release of the first Surgeon General’s report on Smoking and Health in 1964 and subsequent Surgeon General’s reports that have implicated an increasing number of malignancies and other adverse health effects caused by smoking, the federal government ...
Leggi tutto

27 Gennaio 2017

Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer

Recent studies have suggested associations between statins and enhanced survival among patients with pancreatic ductal adenocarcinoma (PDAC). However, the relationship between statins, cholesterol, and survival remains unclear. We conducted a retrospective cohort study on ...
Leggi tutto

27 Gennaio 2017

Immuno-Oncology: There’s More to Discover. A white paper for the multidisciplinary cancer care team

Today, the potential of immunotherapy is being realized as a chief pillar of oncology treatment. From the ﬁ rst cytokine therapy approval by the U.S. Food and Drug and Administration (FDA) in 1986, followed by approval for a prostate cancer cell therapy/vaccine, and ...
Leggi tutto

27 Gennaio 2017

26 gennaio 2017 – Elenchi farmaci innovativi ed orfani richiamati nella nota sulla metodologia applicativa e chiarimenti sull’oggetto delle convocazioni

LAVORIAMO CON

News

MEDICINA DI LABORATORIO, OLTRE IL 70% DELLE DECISIONI CLINICHE DIPENDE DALLE ANALISI. PRESENTATO IL PRIMO STUDIO NAZIONALE SULL’APPLICAZIONE DEL NUOVO NOMENCLATORE TARIFFARIO

TUMORI: “CNAO È CENTRO DI RIFERIMENTO MONDIALE NELL’ADROTERAPIA. A OGGI TRATTATI PIÙ DI 6.200 PAZIENTI”

MALATTIE AUTOIMMUNI: AL GIFFONI FILM FESTIVAL ARRIVA “PIÙ FORTE IO”. CON TENACIA E NUOVE TERAPIE POSSIBILE SUPERARE LE PATOLOGIE CRONICHE

L’OCULISTA: ANCHE IN ESTATE POSSIBILE FARSI OPERARE DI GLAUCOMA. PER PROTEGGERE GLI OCCHI BASTANO MASCHERINE, CAPPELLINI E OCCHIALI

MEDICINA DI LABORATORIO, I CLINICI ITALIANI RICONOSCIUTI TRA LE ECCELLENZE INTERNAZIONALI. “IL NOSTRO PAESE TRA I PROTAGONISTI DELL’EVOLUZIONE DELLA DIAGNOSTICA NEL MONDO”

TUMORE DELL’OVAIO, 1 DONNA SU 3 ASPETTA PIÙ DI UN ANNO PER LA DIAGNOSI. “NECESSARIO AUMENTARE L’ACCESSO AI CENTRI AD ALTO VOLUME, AL SUPPORTO PSICONCOLOGICO E ALL’INNOVAZIONE TERAPEUTICA”

TUMORE DEL SENO, IN ITALIA 950MILA DONNE VIVONO CON UNA DIAGNOSI. ROPI: ‘RACCOMANDATI ALMENO 150 MINUTI D’ATTIVITA’ FISICA ALLA SETTIMANA’

Notizie AIOM – anno XV n. 614

Radiation Therapy for Glioblastoma: What Is New and What Is Missing in the ASCO-Endorsed ASTRO Guidelines

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers

FDA confirms elevated levels of belladonna in certain homeopathic teething products

27 gennaio 2017 – Aggiornamento: Linea guida relativa alle avvertenze degli eccipienti da inserire negli stampati dei medicinali omeopatici

CHMP Recommends Approval of Maintenance Lenalidomide in Post-ASCT Myeloma

American Society of Clinical Oncology Policy Brief: FDA’s Regulation of Electronic Nicotine Delivery Systems and Tobacco Products

Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer

Immuno-Oncology: There’s More to Discover. A white paper for the multidisciplinary cancer care team

26 gennaio 2017 – Elenchi farmaci innovativi ed orfani richiamati nella nota sulla metodologia applicativa e chiarimenti sull’oggetto delle convocazioni